Vanguard Group Inc. Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Vanguard Group Inc. increased its stake in Intuitive Surgical, Inc. by 1.4% this past quarter, now owning approximately 32.67 million shares valued at around $16.18 billion.
• Despite strong quarterly earnings reporting a 21.4% year-over-year revenue increase and surpassing EPS expectations, Intuitive Surgical's stock is down 1.3% at a current price of $477.00.
• Analyst ratings on Intuitive Surgical are mixed, with one downgrade to "sell" while several firms maintained or raised their target prices for the stock, resulting in a consensus rating of "Moderate Buy."

Vanguard Group Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,665,531 shares of the medical equipment provider's stock after purchasing an additional 453,335 shares during the quarter. Vanguard Group Inc. owned about 9.11% of Intuitive Surgical worth $16,178,258,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. AlphaCore Capital LLC raised its position in shares of Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after buying an additional 18 shares during the period. Accredited Investors Inc. raised its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after buying an additional 19 shares during the period. Second Line Capital LLC raised its position in shares of Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares during the period. Colonial Trust Co SC raised its position in shares of Intuitive Surgical by 8.8% during the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock valued at $128,000 after buying an additional 20 shares during the period. Finally, Crown Wealth Group LLC raised its position in shares of Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after buying an additional 20 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 1.3%

NASDAQ:ISRG opened at $477.00 on Wednesday. The company has a fifty day simple moving average of $521.43 and a two-hundred day simple moving average of $531.52. The company has a market cap of $170.99 billion, a price-to-earnings ratio of 66.53, a price-to-earnings-growth ratio of 5.07 and a beta of 1.59. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.78 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares of the company's stock, valued at approximately $9,171,844.80. This trade represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,903 shares of company stock valued at $7,932,778. Insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on ISRG shares. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price target for the company from $515.00 to $440.00 in a research report on Monday, June 9th. BTIG Research lifted their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Royal Bank Of Canada lifted their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a report on Wednesday, July 23rd. Piper Sandler reiterated an "overweight" rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.